Menghesha, Hruy https://orcid.org/0000-0002-0493-2804
Schroeter, Michael
Nelke, Christopher
Ruck, Tobias
Schlachtenberger, Georg
Welskop, Clara
Camo, Amina
Heldwein, Matthias
Bennink, Gerardus
Wahlers, Thorsten
Bölükbas, Servet
Doerr, Fabian
Hekmat, Khosro
Article History
Received: 4 January 2023
Accepted: 24 May 2023
First Online: 15 June 2023
Declarations
:
: The investigation has been conducted in accordance with the Declaration of Helsinki. Due to its retrospective character, the need for written informed consent was waived.
: All authors give their consent for the publication of this manuscript.
: MS participates in the medical advisory board of the German Myasthenia Gravis Foundation (Deutsche Myasthenie Gesellschaft e.V.). Furthermore, MS und KH participate in the Steering group for the German guidelines on myasthenia gravis treatment. TR participates in the medical advisory board of the German Myasthenia Gravis Foundation (Deutsche Myasthenie Gesellschaft e.V.) and received honoraria for lecturing from Alexion, Argenx and UCB.